BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10696560)

  • 1. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.
    Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT
    Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial scleromyxedema. Successful treatment with melphalan].
    Schubert K; Stein A; Meurer M
    Hautarzt; 2002 Jul; 53(7):478-82. PubMed ID: 12219271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients.
    Sansbury JC; Cocuroccia B; Jorizzo JL; Gubinelli E; Gisondi P; Girolomoni G
    J Am Acad Dermatol; 2004 Jul; 51(1):126-31. PubMed ID: 15243538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a patient with scleromyxedema.
    Lee YH; Sahu J; O'Brien MS; D'Agati VD; Jimenez SA
    J Clin Rheumatol; 2011 Sep; 17(6):318-22. PubMed ID: 21869708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a.
    Kumar N; Rodriguez M
    Mult Scler; 2004 Feb; 10(1):85-6. PubMed ID: 14760958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus].
    D'Incan M; Franck F; Kanold J; Bacin F; Achin R; Beyvin AJ; Demeocq F; Souteyrand P
    Ann Dermatol Venereol; 2001 Jan; 128(1):38-41. PubMed ID: 11226899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Scleromyxedema with laryngeal changes. Beneficial results of the treatment with mucopolysaccharidases].
    Cosgarea R; Cosgarea M; Turcu T
    Ann Dermatol Venereol; 1994; 121(2):159-61. PubMed ID: 7979029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrete papular mucinosis-a rare subtype of lichen myxoedematosus.
    Poswig A; Hinrichs R; Megahed M; Hunzelmann N; Kirchberg K; Brenneisen P; Krieg T; Scharffetter-Kochanek K
    Clin Exp Dermatol; 2000 Jun; 25(4):289-92. PubMed ID: 10971487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxedema.
    Wright RC; Franco RS; Denton D; Blaney DJ
    Arch Dermatol; 1976 Jan; 112(1):63-6. PubMed ID: 813582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal scleromyxedema: report of a case and review of the literature.
    Godby A; Bergstresser PR; Chaker B; Pandya AG
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):289-94. PubMed ID: 9486700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.
    Donato ML; Feasel AM; Weber DM; Prieto VG; Giralt SA; Champlin RE; Duvic M
    Blood; 2006 Jan; 107(2):463-6. PubMed ID: 16179379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleromyxedema presenting with neurologic symptoms: a case report and review of the literature.
    Marshall K; Klepeiss SA; Ioffreda MD; Helm KF
    Cutis; 2010 Mar; 85(3):137-40. PubMed ID: 20408512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scleromyxedema: immunosuppressive therapy with cyclophosphamide].
    Aberer W; Wolff K
    Hautarzt; 1988 May; 39(5):277-80. PubMed ID: 3403262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized papular and sclerodermoid eruption: scleromyxedema.
    Serdar ZA; Altunay IK; Yasar SP; Erfan GT; Gunes P
    Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
    Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
    Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cerebral symptomatology, a rare presentation of scleromyxedema.
    Ochitill HN; Amberson J
    J Clin Psychiatry; 1978 May; 39(5):471-5. PubMed ID: 417072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work.
    Lin YC; Wang HC; Shen JL
    J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
    Lacy MQ; Hogan WJ; Gertz MA; Dispenzieri A; Rajkumar SV; Hayman S; Kumar S; Litzow MR; Schroeter AL
    Arch Dermatol; 2005 Oct; 141(10):1277-82. PubMed ID: 16230566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
    Jablonska S; Blaszczyk M
    Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleromyxedema.
    Chanda JJ
    Cutis; 1979 Nov; 24(5):549-52. PubMed ID: 520033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.